GlaxoSmithKline to publish clinical trials after US lawsuit
نویسندگان
چکیده
منابع مشابه
Access to patient-level data from GlaxoSmithKline clinical trials.
Efforts are under way to increase the transparency of clinical trial data. Among the efforts are those being undertaken at GlaxoSmithKline, where we have recently made a commitment to provide access to deidentified patient-level data. We are taking this step because it is the right thing to do, both scientifically and for society, and it is in line with our company’s commitment to transparency ...
متن کاملPatient Safety Requires a New Way to Publish Clinical Trials
The publication of a clinical trial marks the birth of new medical knowledge, and medical editors are the midwives. Although most editors would like to meet expectant researchers shortly after a clinical trial’s conception (or even before), to find out who the parents are and to ensure that the trial receives highquality antenatal care, more often than not labouring researchers arrive at their ...
متن کاملThe need to pursue and publish clinical trials in nanomedicine.
When I became Editor in Chief of Wiley’s WIREs Nanomedicine and Nanobiotechnology, I felt one of the most important issues was that the publication is dedicated to nanomedicines. This essentially suggested that nanotechnology would be transitioning into the actual development of human therapeutics. Recently, this movement has begun. We have seen the initiation of multiple clinical trials of nan...
متن کاملTobacco industry statements in the US Department of Justice lawsuit.
EXECUTIVE SUMMARY Over the last half century, the tobacco industry has earned billions of dollars in profits by selling a deadly and addictive product while denying its harmfulness. As criticism of the industry has accelerated in recent years, and calls for product regulation have grown, tobacco companies have defended themselves by saying they are now “responsible” corporations that aim to com...
متن کاملEvaluation of Clinical Trials
In a number of important clinical issues such as evaluation of the efficacy or effectiveness of therapeutic or preventive interventions as well as for comparing the harms of interventions, randomized controlled trials (RCTs) provide the highest levels of evidence, either directly or indirectly. It is obvious that critical appraisal of these studies to assess their validity and precision is of p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2004
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.328.7455.1513-a